Activation of AMPK as a therapeutic strategy for FBXL4-related mitochondrial DNA depletion syndrome. - Bishnu A; Zapata-Muñoz J; Taylor RW; Sakamoto K; Ganley IG (EMBO molecular medicine, 2026)